Navigation Links
OrbusNeich in Medical News

OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific

...DALE, Fla. and HONG KONG, March 16 /PRNewswire/ -- orbusneich Medical, Inc. ("Orbus" or the "Company"), a design...e many talented people who worked to develop them. orbusneich has an obligation to its investors, employees and ...ing system at www.vaeb.uscourts.gov . About orbusneich ...

OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter

... HONG KONG, June 9 /PRNewswire/ -- orbusneich today announced that it has received CE Mark appro... low crossing profile and unbeatable trackability. orbusneich expects the rapid adoption and integration of the ...er into interventional cardiologists' practices. orbusneich designs, develops, manufactures and markets innova...

OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan

... HONG KONG, May 28 /PRNewswire/ -- orbusneich today announced that it has received approval from...s who have increased risk of thrombotic events." orbusneich designs, develops, manufactures and markets innova...M), Lumina(TM) and Saffron. As a global company, orbusneich is headquartered in Hong Kong and has operations i...

Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeich's Genous(TM) Bio-engineered R stent(TM)

...stent that provides protection against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innovative medical devices for ...TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; ...

OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter

...ability HONG KONG, April 7, 2008 /PRNewswire/ -- orbusneich today announced that it has received CE Mark appro...y Cheem of the University Hospital in Singapore. orbusneich designs, develops, manufactures and markets innova...t(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...

5,000 Patients Treated With OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry

...Eluting Stents HONG KONG, Nov. 8 /PRNewswire/ -- orbusneich today reported that 5,000 patients treated with th...Samuel Rasmussen, OrbusNeich's president and CEO. orbusneich designs, develops, manufactures and markets innova...ut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...

Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents

...ss 2007 VIENNA, Austria, Sept. 3 /PRNewswire/ -- orbusneich today announced that post-marketing data from pati...ection against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innova...ut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...
OrbusNeich in Medical Technology

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

...gies BARCELONA, Spain, May 20 /PRNewswire/ -- orbusneich announced today that two year follow up data from ...ding a safe and effective alternative to DES. orbusneich designs, develops, manufactures and markets innova..., Avita HP, and Lumina(TM). A global company, orbusneich is headquartered in Hong Kong and has operations i...

Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)

...plex Lesions WASHINGTON, Oct. 14 /PRNewswire/ -- orbusneich today announced that an interim analysis of 12-mon...ction against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innova...t(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...

Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008

...place at 5:04 p.m. EDT on Oct. 13 in Ballroom C at the convention center. orbusneich designs, develops, manufactures and markets innovative medical devices for ...TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; ...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

... HONG KONG, July 7 /PRNewswire/ -- orbusneich today announced that data presented recently at th...ction against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innova...M), Lumina(TM) and Saffron. As a global company, orbusneich is headquartered in Hong Kong and has operations i...

Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents

...Therapy BARCELONA, Spain, May 15 /PRNewswire/ -- orbusneich today announced that multiple clinical data presen...ction against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innova...t(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...

Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008

...ction against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innova...t(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...isit http://www.OrbusNeich.com . Editor's Note: orbusneich will display the Genous Bio-engineered R stent at ...

Clinical Impact of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology

...stent that provides protection against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innovative medical devices for ...TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; ...

OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007

... stent that provides protection against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innovative medical devices for ...(TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; ...

Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents

...r at TCT 2007 in Washington, D.C. -- orbusneich reported that 52 patients have received the Genous...ction against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innova...t(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations i...
OrbusNeich in Biological Technology

OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients

...By integrating these onto one innovative platform, orbusneich is making tremendous strides in being able to offe...ding a safe and effective alternative to DES. orbusneich designs, develops, manufactures and markets innova..., Avita HP, and Lumina(TM). A global company, orbusneich is headquartered in Hong Kong and has operations i...

Interim Analysis of Data from e-HEALING Registry of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008

...stent that provides protection against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innovative medical devices for ...TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; ...

OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports

...stent that provides protection against thrombus and minimizes restenosis. orbusneich designs, develops, manufactures and markets innovative medical devices for ...TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. A global company, orbusneich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; ...
Other Tags
(Date:7/28/2014)... (July 28, 2014) -- Researchers from The University of Texas ... and other institutions have identified a combination of pills that ... of the drugs sofosbuvir and simeprevir, with or without ribavirin, ... well tolerated by patients, according to the study published today ... conducted in the U.S. , Eric Lawitz, M.D., clinical ...
(Date:7/28/2014)... North America Carotenoids & Antioxidants Market report defines and segments ... and forecast of revenue. This market is estimated to grow ... 2018, at a CAGR of 7.1% from 2013 to 2018. ... & Antioxidants Market report to get an idea of the ... segmentation in the market, and is supported by various tables ...
(Date:7/28/2014)... The Oneida Indian Nation today announced that golf ... PGA TOUR players will be teeing up with four-time ... for the seventh annual Notah Begay III Foundation (NB3F) ... Atunyote® Golf Club on Wednesday, August 27, the star-studded ... Walker, Jonas Blixt, Angel Cabrera and Louis Oosthuizen, in ...
(Date:7/28/2014)... San Jose, CA (PRWEB) July 28, 2014 ... and family life Americans face today, BlogHer, The Center ... up to launch “Make Life Work,” a campaign to ... faced by families across the U.S. The joint initiative ... by Stacy Morrison, Editor-in-Chief, BlogHer; Judith Warner, Senior Fellow, ...
(Date:7/28/2014)... 28, 2014 According to a ... Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology (CVD, ... (Power, Opto-electronic), Application, and Geography-2013-2020", published by MarketsandMarkets, ... CAGR of 12.63% from 2014 to 2020 and ... market data tables and 88 figures spread through ...
Breaking Medicine News(10 mins):Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4
(Date:7/28/2014)... 2014) Rice University researchers are using magnetic beads ... that can be used as microscale models for polymer ... polymers, introduced as theory in the 1950s, can be ... should be of interest to materials scientists who study ... by Rice chemical and biomolecular engineer Sibani Lisa Biswal ...
(Date:7/28/2014)... July 28, 2014 Research and Markets ... Market in Latin America 2014-2018" report to their ... Biometrics measure and analyze biological data. These systems ... eye retinas, voice patterns, and hand measurements from the ... stored templates. The main purpose of a biometrics system ...
(Date:7/28/2014)... Institute for Biologically Inspired Engineering at Harvard University ... be commercialized by a newly formed private company ... personalized medicine products. The announcement follows ... Technology Development (OTD) and the start-up Emulate Inc., ... human Organs-on-Chips platform. , "This is a ...
Breaking Biology News(10 mins):Seeing is bead-lieving 2Biometrics Market in Latin America 2014-2018 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3
Other Contents